Posted in

Vector Vaccines: Notable Examples and Applications in Human and Animal Health

Vector Vaccines: Notable Examples and Applications in Human and Animal Health I. Viral Vector Vaccines 1. Human Medicine a. Adenoviral Vectors COVID-19 Vaccines: ChAdOx1 (AstraZeneca): A chimpanzee adenovirus vector delivers the SARS-CoV-2 spike protein gene, achieving ~70% efficacy with a single do … Vector Vaccines: Notable Examples and Applications in Human and Animal HealthRead more

Posted in

LNP Vax: Breakthroughs and Clinical Pathways for Lung Cancer Prevention

LNP Vax: Breakthroughs and Clinical Pathways for Lung Cancer Prevention As the leading cause of global cancer mortality, lung cancer prevention has long been constrained by limitations in early screening. The LNP Vax, a lipid nanoparticle (LNP)-based preventive vaccine, is revolutionizing protection … LNP Vax: Breakthroughs and Clinical Pathways for Lung Cancer PreventionRead more

Posted in

Latest Advances and Future Prospects of LNP Cores in mRNA Vaccines (2025 Comprehensive Analysis)

Latest Advances and Future Prospects of LNP Cores in mRNA Vaccines (2025 Comprehensive Analysis) The lipid nanoparticle (LNP) core is the cornerstone of mRNA vaccine delivery systems, with its composition (ionizable lipids, helper lipids, cholesterol, PEG-lipids) and physicochemical properties direc … Latest Advances and Future Prospects of LNP Cores in mRNA Vaccines (2025 Comprehensive Analysis)Read more

Posted in

Contraindications of COVID-19 Antiviral Therapies: A Comprehensive Analysis

Contraindications of COVID-19 Antiviral Therapies: A Comprehensive Analysis (As of May 2025) I. Key Contraindications of Major Antivirals 1. Paxlovid (Nirmatrelvir/Ritonavir) Absolute Contraindications: Hypersensitivity to nirmatrelvir or ritonavir (e.g., Stevens-Johnson syndrome, toxic epidermal ne … Contraindications of COVID-19 Antiviral Therapies: A Comprehensive AnalysisRead more

Posted in

Comprehensive Analysis of SARS-CoV-2 Variants and Emerging Treatments

Comprehensive Analysis of SARS-CoV-2 Variants and Emerging Treatments (As of May 2025) I. Key Variants and Epidemiological Features 1. Dominant Circulating Variants XBB.1.5 (“Kraken”): Transmissibility: WHO designates it as the most transmissible Omicron subvariant, with a 3–5x higher R0 … Comprehensive Analysis of SARS-CoV-2 Variants and Emerging TreatmentsRead more

Posted in

Viral Vector-AI Convergence: Disruptive Innovations in Longevity Medicine

Viral Vector-AI Convergence: Disruptive Innovations in Longevity Medicine (Systematic Review as of May 2025) The synergy between viral vector technology and artificial intelligence (AI) is redefining anti-aging research. Through breakthroughs in precision delivery, intelligent design, and dynamic re … Viral Vector-AI Convergence: Disruptive Innovations in Longevity MedicineRead more